Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track NCEL with free AI briefings, catalyst countdowns, and dilution alerts.

NCEL · NewcelX Ltd.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$710,000 Cash on Hand

1.7mo Cash Runway

Follow NCEL by email Get an email when NCEL pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about NCEL, unsubscribe in one click. Privacy

💰 Cash Runway & Dilution Risk

NCEL holds $710,000 in cash and short-term investments and burns about $1.3M/quarter from operations, an estimated runway of 1.7 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 75 · High

Cash runway 2 months +40
Going-concern doubt in the latest 20-F +15This raises substantial doubt about its ability to continue as a going concern. 20-F, Apr 2026
Share count +52% in a year +20

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when NCEL files for a raise →

Get the full NCEL picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for NCEL and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z